Máxima Medisch Centrum is a teaching hospital in the Netherlands, on two locations, in Veldhoven and Eindhoven. It was founded in 2002 through the merger of the Sint-Josephziekenhuis in Veldhoven and the Diaconessenhuis in Eindhoven, and was named after Queen Máxima of the Netherlands.

During the past decade, Maxima Medisch Centrum conducted 107 clinical trials. In the 10-year time frame, 107 clinical trials started and 16 clinical trials were completed, i.e. on average, 15% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 9 clinical trials were completed. i.e. 15.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maxima Medisch Centrum" #1 sponsor was "Radboud University Medical Center" with 18 trials, followed by "Maastricht University Medical Center" with 12 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 9 trials sponsored, "The Netherlands Cancer Institute" with 8 trials sponsored and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 8 trials sponsored. Other sponsors include 102 different institutions and companies that sponsored additional 74 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maxima Medisch Centrum" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 24 trials as a collaborator, "Erasmus Medical Center" with 9 trials as a collaborator, "Borstkanker Onderzoek Groep" with 7 trials as a collaborator, "Maxima Medical Center" with 7 trials as a collaborator and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 6 trials as a collaborator. Other collaborators include 224 different institutions and companies that were collaborators in the rest 168 trials.

According to Clinical.Site data, the most researched conditions in "Maxima Medisch Centrum" are "Breast Cancer" (10 trials), "Heart Failure" (6 trials), "Breast Neoplasms" (4 trials), "Crohn Disease" (4 trials) and "Ovarian Cancer" (4 trials). Many other conditions were trialed in "Maxima Medisch Centrum" in a lesser frequency.

Most popular intervention types in "Maxima Medisch Centrum" are "Drug" (83 trials), "Procedure" (30 trials), "Other" (24 trials), "Device" (15 trials) and "Behavioral" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Cyclophosphamide" (4 trials), "Docetaxel" (4 trials), "Nivolumab" (4 trials) and "Bevacizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Maxima Medisch Centrum" are 128 trials for "All" genders, 27 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 76 active trials in "Maxima Medisch Centrum". 3 are not yet recruiting, 42 are recruiting, 28 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 49 completed trials in Maxima Medisch Centrum, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Maxima Medisch Centrum, 2 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 43 trials that are defined as “Not Applicable".